Vcanbio Cell & Gene Engineering Corp., Ltd (SHA:600645)
China flag China · Delayed Price · Currency is CNY
17.78
-0.24 (-1.33%)
Sep 11, 2026, 3:00 PM CST

SHA:600645 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
115.45113.83100.35106.45112.99155.32
Depreciation & Amortization
134.31130.69141.97143.6138.21124.62
Other Amortization
30.8134.2728.129.0226.1223.09
Loss (Gain) From Sale of Assets
-8.05-6.41-1.3-3.67-2.03-1.49
Asset Writedown & Restructuring Costs
1.311.344.680.310.827.64
Loss (Gain) From Sale of Investments
9.767.9244.3347.948.71-85.87
Provision & Write-off of Bad Debts
9.9121.9327.6820.917.6338.21
Other Operating Activities
-1.460.93.122.09-2.04-5.18
Change in Accounts Receivable
7.89-20.2-31.23-12.23-31.9330.73
Change in Inventory
-8.89-7.36-0.63-9.25-27.64-4.56
Change in Accounts Payable
-8-3.37-11.18-1.0735.0619.42
Change in Other Net Operating Assets
---0.0312.21-6.68-19.46
Operating Cash Flow
323.2313.63285.19299.02261.89320.96
Operating Cash Flow Growth
4.40%9.97%-4.62%14.18%-18.40%31.35%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-44.87-49.56-67.32-88.61-99.19-127.74
Sale of Property, Plant & Equipment
0.160.310.780.191.4212.63
Investment in Securities
89.3-710.331.95-2.06-0.57-18.95
Other Investing Activities
10.9411.740.72---
Investing Cash Flow
55.51-747.85-63.86-90.49-98.34-134.05

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--65.04-41.19-35.76-41.33-29.13
Lease Payments
-39.47-65.04-25.42-29.45-35.02-22.82
Net Debt Issued (Repaid)
-39.47-65.04-41.19-35.76-41.33-29.13
Repurchase of Common Stock
---200.03---
Common Dividends Paid
------1.61
Other Financing Activities
-24.03-9.07-43.6917.0333.58-18.97
Financing Cash Flow
-63.5-74.1-284.91-18.73-7.75-49.71

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-19.59-9.257.310.2235.3-7.44
Net Cash Flow
295.63-517.56-56.28200.02191.1129.75

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
278.33264.07217.87210.4162.7193.22
Free Cash Flow Growth
7.17%21.21%3.55%29.32%-15.79%26.59%
Free Cash Flow Margin
19.91%18.15%13.74%13.23%10.46%12.58%
Free Cash Flow Per Share
0.590.580.480.460.350.41
Levered Free Cash Flow
224.47195.78191.89164.65141.27197.98
Unlevered Free Cash Flow
225.36197.8195.03167.79143.78199.95
Free Cash Flow After Leases
238.86199.04192.45180.95127.68170.39

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
--0.590.921.27-
Cash Income Tax Paid
161.65159.44162.15170.94110.96116.78
Change in Working Capital
31.179.17-63.75-47.63-38.4944.62